Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 10, 2025 • 6:00 AM ET

Date/Time Source News Release
03/21/2025 10:45 AM EDT PR Newswire TCBP Announces Transition from Nasdaq to OTC Markets
03/18/2025 08:03 AM EDT PR Newswire TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead
03/05/2025 08:30 AM EST PR Newswire TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company
02/20/2025 08:00 AM EST PR Newswire TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum
02/13/2025 08:30 AM EST PR Newswire TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial
02/10/2025 10:00 AM EST PR Newswire TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial
02/05/2025 12:00 PM EST PR Newswire TCBP to Implement ADS Ratio Change
01/15/2025 08:30 AM EST PR Newswire TCBP Announces H5N1 Proof of Concept Studies Intention
01/13/2025 08:45 AM EST PR Newswire TCBP to Present at Sequire Investor Summit 2025
01/06/2025 09:26 PM EST PR Newswire /C O R R E C T I O N -- TC BioPharm/
Page